Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

UBROGEPANT vs ULIPRISTAL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

UBROGEPANT vs ULIPRISTAL: Safety Overview

Metric UBROGEPANT ULIPRISTAL
Total FAERS Reports 2,531 660
Deaths Reported 49 8
Death Rate 1.9% 1.2%
Hospitalizations 145 112
Average Patient Age 49.2 yrs 35.2 yrs
% Female Patients 83.6% 98.1%
FDA Approval Date Dec 23, 2019 Aug 13, 2010
Manufacturer Allergan, Inc. A-S Medication Solutions
Route ORAL ORAL
Marketing Status Prescription Prescription